Andreas Lindenschmidt

USPTO Granted Patents = 18 (Patent Applications = 1)

EPO Patents = 3

Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 81(Granted Patents)

Company Filing History:

15 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

patents

3 out of 330

Aventis Pharma Deutschland, Gmbh

patents

Years Active: 2002-2014

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8710232 - Imidazole derivatives used as TAFIa inhibitors (2014-04-29),

2. 7772429 - Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use (2010-08-10),

3. 7674773 - Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use (2010-03-09),

4. 7671047 - Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2010-03-02),

5. 7652143 - Cyclic ureas used as inhibitors of metalloproteases (2010-01-26),

6. 7579339 - Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2009-08-25),

7. 7576200 - Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use (2009-08-18),

8. 7488829 - Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use (2009-02-10),

9. 7488818 - Method for producing 1,4-diphenyl azetidinone derivatives (2009-02-10),

10. 7407938 - Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2008-08-05),

11. 7390790 - Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2008-06-24),

12. 7388004 - Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2008-06-17),

13. 7205290 - Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use (2007-04-17),

14. 7176194 - Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2007-02-13),

15. 7176193 - Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use (2007-02-13),

Title: The Innovations of Andreas Lindenschmidt

Introduction

Andreas Lindenschmidt is a notable inventor based in Bad Soden, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 18 patents. His work primarily focuses on developing compounds that have therapeutic applications, particularly in the treatment of thrombotic conditions.

Latest Patents

Among his latest patents is the invention of imidazole derivatives used as TAFIa inhibitors. This invention relates to compounds that inhibit the activated thrombin-activatable fibrinolysis inhibitor. These compounds are particularly suited for producing medicaments aimed at preventing and treating diseases associated with thromboses, embolisms, hypercoagulability, or fibrotic changes. Another significant patent involves diphenylazetidinone with improved physiological properties. This invention details a compound that is suitable for use as a hypolipidemic and includes its preparation process and potential applications in medicaments.

Career Highlights

Throughout his career, Lindenschmidt has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Lindenschmidt has collaborated with several professionals in his field, including Wendelin Frick and Gerhard Jaehne. These collaborations have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Andreas Lindenschmidt's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the pharmaceutical industry. His work continues to impact the development of important therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.